Prelude Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Prelude Capital Management’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,300	Closed	-$15K	–	2348
2018 Q4	$15K	Buy	1,300 +969	+293%	+$16.5K	﹤0.01%	1295
2018 Q3	$7K	Sell	331 -2,618	-89%	-$49.5K	﹤0.01%	1604
2018 Q2	$47K	Buy	2,949 +1,482	+101%	+$23.3K	﹤0.01%	1133
2018 Q1	$28K	Sell	1,467 -3,433	-70%	-$67.7K	﹤0.01%	1217
2017 Q4	$85K	Buy	+4,900	New	+$67.6K	0.01%	826
2016 Q4	–	Sell	-2,300	Closed	-$42K	–	1885
2016 Q3	$42K	Buy	2,300 +1,500	+188%	+$33.8K	﹤0.01%	1103
2016 Q2	$23K	Buy	+800	New	+$22.3K	﹤0.01%	1237

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prelude Capital Management's ARA Position: Q1 2019 in Review

Prelude Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2019, closing a stake of 1,300 shares — an estimated $15K sold.

Prelude Capital Management first reported a position in ARA in Q2 2016 and held it in 7 quarters. The position peaked at $85K in Q4 2017. 68 funds tracked by Wall St. Rank hold ARA as of Q1 2019.

Prelude Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2019 after selling out during the quarter.
Prelude Capital Management sold 1,300 American Renal Associates Holdings, Inc shares in Q1 2019, an estimated $15K.
Prelude Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 7 quarters.
Prelude Capital Management's American Renal Associates Holdings, Inc position peaked at $85K in Q4 2017.
68 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.